Suramin and hydrocortisone: Determining drug efficacy in androgen-independent prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Hydrocortisone
  • Prostatic Neoplasms
  • Suramin
  • Testosterone

abstract

  • The administration of suramin was simplified and the drug concentrations were maintained. In this cohort of patients with advanced prostate cancer, the clinical activity of suramin using these dosing schedules was limited. Pharmacodynamic issues, patients selection, and criteria to assess efficacy could have effected the clinical outcome.

publication date

  • September 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7666079

Additional Document Info

start page

  • 2214

end page

  • 22

volume

  • 13

number

  • 9